Since 2011, the members of NAPAAC have joined forces in order to make rapid advances in our ability to treat children with aplastic anemia, inherited bone marrow failure syndromes (IBMFS), and Myelodysplastic Syndrome (MDS). Boston Children’s Hospital serves as the data coordinating center for the Consortium by providing infrastructure and technical support.

NAPAAC is led by an Executive Committee which is elected by the Steering Committee composed of the principal investigators from each member institution. ​